Papers

3

Total Citations

107

H-Index

3

About

Dr. Fadi Darwiche is a leading urologic oncologist whose research centers on advancing minimally invasive surgical techniques for the treatment of kidney and upper tract cancers. His work has been instrumental in evaluating and refining robotic-assisted procedures, particularly for complex malignancies. Dr. Darwiche’s most impactful study, with 47 citations, critically compared the oncologic outcomes of minimally invasive versus open radical nephrectomy for locally advanced renal-cell carcinoma, providing crucial evidence that a minimally invasive approach can be safe and effective in these challenging cases. He is also recognized for pioneering the operative technique for robotic-assisted laparoscopic nephroureterectomy (RALNU) using the da Vinci Xi system, a landmark paper with 38 citations that established a new standard for managing upper tract urothelial carcinoma. Furthermore, his detailed description of robotic partial nephrectomy with the da Vinci Xi platform (22 citations) has helped surgeons worldwide adopt this advanced technology for nephron-sparing surgery. Through these contributions, Dr. Darwiche has significantly shaped the modern surgical landscape, demonstrating that robotic approaches can achieve excellent outcomes while reducing patient morbidity.

Research Focus

Key Achievements

3
H-Index
3
Papers
107
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of Minimal Invasive <i>vs</i> Open Radical Nephrectomy for the Treatment of Locally Advanced Renal-Cell Carcinoma
47 citations · 2016
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Roswell Park Comprehensive Cancer Center, University of Miami

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago